Obesity101.com THE LATEST IN OBESITY RESEARCH AND WEIGHTLOSS DRUG DEVELOPMENT Join our list More information Obesity 101 index page Obesity 101 is a primer offered to Obesity-news subscribers on the theories and major issues concerning obesity research and the development of medications. Some sections will cover the basics, others will cover more complex subjects, like how the various brain and gut peptides regulate energy expenditure, and the major theories on obesity. The purpose of Obesity 101 is to form a compendium on all aspects of obesity research for subscribers to use as a reference tool. | PASSWORD REMINDER | SUBSCRIBER LOG-IN | Accuracy in medical reporting: A consumer's guide. Before you even get started, you may want to read our consumer's guide on accuracy in medical reporting. It will give you tips on what goes into good medical writing, and what you should look for when you visit health care sites on the internet. The basics Introduction: What is obesity? Over-the-counter supplements and weight loss. Neurotransmitters, hormones and peptides Overview: Obesity and the hypothalamus. (subscribers) Mini review: Catecholamines and fat metabolism. (subscribers) Beta adrenergic receptors and obesity. (subscribers) ß-endorphins, opioids and obesity. (subscribers) Cannabinoids and body weight. (subscribers) Glucagon-like peptide. Growth hormone in obesity. (subscribers) Histamine and obesity. (subscribers) Leptin in human obesity. (subscribers) PPARs: Insulin sensitizers for type-2 diabetes and weight loss. (subscribers) Serotonin Brain serotonin neurotransmission. (subscribers) Serotonin and eating disorders. (subscribers) Serotonin, gut peptides and appetite regulation. (subscribers) SSRIs in the treatment of eating disorders. (subscribers) Diet and nutrition Calcium and weight loss. Calorie restriction and longevity. (subscribers) Dietary fat and leptin resistance. Food and hormones: Hormonal balance and the Zone Diet. (subscribers) Hedonics: Taste preferences, food intake and obesity. (subscribers) The glycemic index. (subscribers) Drug development Bringing a new drug to market. Weight loss and diabetes drug development database. (subscribers) The Obesity-news database of 200 plus investigative weight loss and diabetes drugs, updated monthly. Pipeline by company name. (subscribers) A comprehensive list of companies that either manufacture or are developing medications to treat obesity. Each listing indicates which drugs the company manufactures or has in its pipeline. Each listing has hyperlinks to press releases, product pipeline, and newsletter articles on the drug or drug candidate, when available. This list is updated monthly. Over-the-counter drugs Conjugated linoleic acid and body composition. (subscribers) Ephedra supplements and weight loss. (subscribers) Ephedrine and thermogenesis. (subscribers) Insulin resistance syndrome Insulin resistance and obesity. (subscribers) Metformin and weight loss. (subscribers) The metabolically obese, normal weight person. (subscribers) Obesity theories Obesity: genetic, metabolic and environmental factors. (subscribers) Obesity and body weight set points. (subscribers) Obesity virus: Could a virus cause obesity? Frequently asked questions pages Our frequently asked questions pages have been updated and separated into sections for easier loading and browsing. The newest additions to our extensive FAQ list are the drugs in development FAQ, which lists compounds in human testing and preclinical development, and the over-the-counter medications FAQ, which will help you separate the wheat from the chaff when you look for weight loss aids at your local health food store or vitamin shop. OTC medications and supplements. Weight loss drugs in development. Meridia. Off-label prescribing practices. Prescription obesity medications. OMR surveys Meridia survey results. Phen/fen and heart valve damage survey results. Phen/fen maintenance survey results. Home|Subscribe|Archives|Drug info|Contact|Media & Links|Site index|FAQs|Doctors/meetings|Admin Obesity-news is a publication of Hirsch Communications. An on-line subscription is $104.00 per year, payable in advance by check, money order, American Express, VISA or Mastercard. Subscribing is simple using our secure on-line subscription form. Obesity-news also accepts fax orders at 703/960-7462. Copyright 1997-2009, all rights reserved. IMPORTANT: All information in this publication is believed to be accurate and true. Publisher is not liable for omissions or inaccuracies. Information in this newsletter is for educational purposes only and should not be construed as medical advice, or be used in lieu of consultation with a health care provider.